Krista L. Dobo

1.8k total citations
42 papers, 947 citations indexed

About

Krista L. Dobo is a scholar working on Cancer Research, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Krista L. Dobo has authored 42 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cancer Research, 15 papers in Molecular Biology and 13 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Krista L. Dobo's work include Carcinogens and Genotoxicity Assessment (27 papers), Water Treatment and Disinfection (7 papers) and Effects and risks of endocrine disrupting chemicals (6 papers). Krista L. Dobo is often cited by papers focused on Carcinogens and Genotoxicity Assessment (27 papers), Water Treatment and Disinfection (7 papers) and Effects and risks of endocrine disrupting chemicals (6 papers). Krista L. Dobo collaborates with scholars based in United States, United Kingdom and Switzerland. Krista L. Dobo's co-authors include Michelle Kenyon, Nigel Greene, Warren W. Ku, Joel P. Bercu, Stéphane Caron, Susanne Glowienke, Wolfgang Muster, R. Scott Obach, John Nicolette and Stephanie L. Coffing and has published in prestigious journals such as Journal of Bacteriology, Journal of Medicinal Chemistry and Carcinogenesis.

In The Last Decade

Krista L. Dobo

41 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Krista L. Dobo United States 20 420 289 241 199 136 42 947
Laura Custer United States 16 306 0.7× 213 0.7× 164 0.7× 175 0.9× 62 0.5× 22 673
Susanne Glowienke Switzerland 16 237 0.6× 136 0.5× 172 0.7× 221 1.1× 94 0.7× 28 700
Andreas Czich Germany 19 274 0.7× 293 1.0× 175 0.7× 168 0.8× 61 0.4× 30 875
Joel P. Bercu United States 20 203 0.5× 154 0.5× 201 0.8× 102 0.5× 85 0.6× 45 725
Wolfgang Muster Switzerland 13 192 0.5× 220 0.8× 85 0.4× 324 1.6× 81 0.6× 26 742
Edwin J. Matthews United States 23 443 1.1× 318 1.1× 288 1.2× 746 3.7× 136 1.0× 48 1.4k
Gregory L. Kedderis United States 21 440 1.0× 358 1.2× 292 1.2× 74 0.4× 35 0.3× 43 1.4k
Kevin P. Cross United States 18 147 0.3× 260 0.9× 156 0.6× 343 1.7× 100 0.7× 41 735
Neela B. Manley United States 13 510 1.2× 247 0.9× 334 1.4× 204 1.0× 36 0.3× 18 934
Jacky Van Gompel Belgium 12 267 0.6× 216 0.7× 142 0.6× 106 0.5× 28 0.2× 18 668

Countries citing papers authored by Krista L. Dobo

Since Specialization
Citations

This map shows the geographic impact of Krista L. Dobo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krista L. Dobo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krista L. Dobo more than expected).

Fields of papers citing papers by Krista L. Dobo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krista L. Dobo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krista L. Dobo. The network helps show where Krista L. Dobo may publish in the future.

Co-authorship network of co-authors of Krista L. Dobo

This figure shows the co-authorship network connecting the top 25 collaborators of Krista L. Dobo. A scholar is included among the top collaborators of Krista L. Dobo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krista L. Dobo. Krista L. Dobo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yu, Shu, J. Christopher McWilliams, Olivier Dirat, et al.. (2024). A Kinetic Model for Assessing Potential Nitrosamine Carcinogenicity. Chemical Research in Toxicology. 37(8). 1382–1393. 5 indexed citations
3.
Bercu, Joel P., Olivier Dirat, Krista L. Dobo, et al.. (2024). N-Nitrosamine drug substance related impurities (NDSRIs) – A proposal for the addition of subcategories to carcinogenic potency categorization approach categories 1 and 2 for NDSRIs with a molecular weight > 200 Da. Regulatory Toxicology and Pharmacology. 154. 105704–105704. 7 indexed citations
4.
Snodin, David J., Alejandra Trejo‐Martin, David J. Ponting, et al.. (2024). Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic Potency. Chemical Research in Toxicology. 37(2). 181–198. 28 indexed citations
5.
Ponting, David J., Krista L. Dobo, Michelle Kenyon, & Amit S. Kalgutkar. (2022). Strategies for Assessing Acceptable Intakes for Novel N-Nitrosamines Derived from Active Pharmaceutical Ingredients. Journal of Medicinal Chemistry. 65(23). 15584–15607. 27 indexed citations
6.
Dobo, Krista L., Michelle Kenyon, Olivier Dirat, et al.. (2022). Practical and Science-Based Strategy for Establishing Acceptable Intakes for Drug Product N-Nitrosamine Impurities. Chemical Research in Toxicology. 35(3). 475–489. 62 indexed citations
7.
Dobo, Krista L., et al.. (2018). 2‐Hydroxypyridine‐N‐oxide (HOPO): Equivocal in the ames assay. Environmental and Molecular Mutagenesis. 59(4). 312–321. 2 indexed citations
8.
Heard, Pamela L., et al.. (2017). Fluorescent tubulin polymerization assay to characterize moa of genotoxic compounds — A validation study. Journal of Pharmacological and Toxicological Methods. 85. 89–89. 1 indexed citations
9.
Greene, Nigel, Krista L. Dobo, Michelle Kenyon, et al.. (2015). A practical application of two in silico systems for identification of potentially mutagenic impurities. Regulatory Toxicology and Pharmacology. 72(2). 335–349. 32 indexed citations
10.
Barber, Chris, Alexander Amberg, Laura Custer, et al.. (2015). Establishing best practise in the application of expert review of mutagenicity under ICH M7. Regulatory Toxicology and Pharmacology. 73(1). 367–377. 51 indexed citations
11.
Sutter, Andreas, Alexander Amberg, Scott Boyer, et al.. (2013). Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities. Regulatory Toxicology and Pharmacology. 67(1). 39–52. 88 indexed citations
12.
Dobo, Krista L., Nigel Greene, Charlotta Fred, et al.. (2012). In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: An industry survey. Regulatory Toxicology and Pharmacology. 62(3). 449–455. 62 indexed citations
13.
Sobol, Zhanna, Richard A. Spellman, Dingzhou Li, et al.. (2012). Development and validation of an in vitro micronucleus assay platform in TK6 cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 746(1). 29–34. 28 indexed citations
14.
Bercu, Joel P., Krista L. Dobo, Elmar Gocke, & Timothy J. McGovern. (2009). Overview of Genotoxic Impurities in Pharmaceutical Development. International Journal of Toxicology. 28(6). 468–478. 32 indexed citations
15.
Dobo, Krista L., et al.. (2009). Concordance analysis of an in vitro micronucleus screening assay and the regulatory chromosome aberration assay using pharmaceutical drug candidates. Environmental and Molecular Mutagenesis. 51(1). 39–47. 9 indexed citations
16.
Spellman, Richard A., et al.. (2008). Improving dose selection and identification of aneugens in the in vitro chromosome aberration test by integration of flow cytometry‐based methods. Environmental and Molecular Mutagenesis. 49(4). 318–327. 11 indexed citations
17.
Obach, R. Scott & Krista L. Dobo. (2008). Comparison of metabolite profiles generated in Aroclor‐induced rat liver and human liver subcellular fractions: Considerations for in vitro genotoxicity hazard assessment. Environmental and Molecular Mutagenesis. 49(8). 631–641. 18 indexed citations
18.
19.
20.
Dobo, Krista L., et al.. (1995). Extensive loss of heterozygosity accounts for differential mutation rate on chromosome 17q in human lymphoblasts. Mutagenesis. 10(1). 53–58. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Custer Breakdown of academic impact, for papers by Susanne Glowienke Breakdown of academic impact, for papers by Andreas Czich Breakdown of academic impact, for papers by Joel P. Bercu Breakdown of academic impact, for papers by Wolfgang Muster Breakdown of academic impact, for papers by Edwin J. Matthews Breakdown of academic impact, for papers by Gregory L. Kedderis Breakdown of academic impact, for papers by Kevin P. Cross Breakdown of academic impact, for papers by Neela B. Manley Breakdown of academic impact, for papers by Jacky Van Gompel
Rankless by CCL
2026